semaglutide cvot trial In patients with type 2 diabetes and atherosclerotic cardiovascular disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. ⁣ ⁣ Read the full SURPASS-CVOT results and Research Summary The SELECT Trial - A

After your first injection, some medication remains when you take your second dose a week later

The rise of GLP-1 agonist drugs in Type 2 diabetes and anti-obesity

The conversion between the two medications is not straightforward because they target different receptor combinations

PlexusDx compounded semaglutide injection is available across all 50 states without insurance requirements, making it accessible for many populations, though individual eligibility still depends on the comprehensive health assessment

, ()

Fella Health includes video-chat sessions with a personal health coach every two weeks and ongoing text support between sessions